Skip to main content
. Author manuscript; available in PMC: 2022 Nov 30.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2022 Feb 12;25(4):755–761. doi: 10.1038/s41391-022-00497-7

Figure 2.

Figure 2.

Genetic-risk-adjusted cumulative incidence curves for PHS290. Curves are shown for the upper 5th (>95th) and upper 20th (>80th) percentile of PHS290 for clinically significant and non-clinically-significant prostate cancer. The reference curves represent the overall population average from the UK.

HHS Vulnerability Disclosure